美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40059 A II 2024/09/05 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD LASMIDITAN HEMISUCCINATE
40179 A II 2024/09/05 TAPI NL BV TRILACICLIB
40242 A II 2024/09/05 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD HS-20098
40360 A II 2024/09/04 ARENE LIFE SCIENCES PRIVATE LTD CLOPIDOGREL BISULFATE USP
40427 A II 2024/09/04 SICHUAN HUIYU PHARMACEUTICAL CO LTD LEUCOVORIN CALCIUM
40480 A II 2024/09/04 JIANGSU EAST-MAB BIOMEDICAL TECHNOLOGY CO LTD RECOMBINANT ANTI-HUMAN CD28 MAB
39853 A II 2024/09/04 JIANGSU HANSOH PHARMACEUTICAL CO LTD ENZALUTAMIDE
40322 A II 2024/09/04 SHANDONG XINHUA PHARMACEUTICAL CO LTD GLIMEPIRIDE (II)
40384 A II 2024/09/03 ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD SIMVASTATIN
40456 A II 2024/09/03 CDYMAX (INDIA) PHARMA PRIVATE LTD GEFITINIB
40290 A II 2024/09/03 SHANDONG NEW TIME PHARMACEUTICAL CO LTD DECITABINE
40300 A II 2024/09/03 BESTCHROM (ZHEJIANG) BIOSCIENCES LTD AT PROTEIN A DIAMOND
40316 A II 2024/09/03 FUKOKU CO LTD CELL CULTURE MEDIUM
40400 A II 2024/09/02 SHAOXING JINGXIN PHARMACEUTICALS CO LTD ROSUVASTATIN CALCIUM INTERMEDIATE (R1)
40423 A III 2024/09/02 MERAKI ENTERPRISES PLAIN AND PRINTED BLISTER FOIL, STRIP FOIL, LAMINATES AND PAPER FOIL USED AS PRIMARY PACKAGING MATERIAL FOR PHARMACEUTICAL AND FOOD PROCESSING INDUSTRIES
40434 A II 2024/09/02 JIANGSU EAST-MAB BIOMEDICAL TECHNOLOGY CO LTD RECOMBINANT HUMAN TGF-ß1
40331 A II 2024/08/31 HONOUR LAB LTD PIRFENIDONE (PROCESS-II)
40435 A II 2024/08/31 JIANGSU EAST-MAB BIOMEDICAL TECHNOLOGY CO LTD RECOMBINANT ANTI-HUMAN CD16 MAB
40443 A II 2024/08/31 RAJASTHAN ANTIBIOTICS LTD MEROPENEM FOR INJECTION USP [STERILE BLEND OF MEROPENEM USP (83%) AND SODIUM CARBONATE USP (17%)]
40446 A II 2024/08/31 MAITHRI DRUGS PRIVATE LTD ZINC SULFATE HEPTAHYDRATE USP

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files